product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
FGF-8 Antibody (001) [DyLight 550]
catalog :
NBP2-90327R
quantity :
0.1 ml
price :
569 USD
clonality :
monoclonal
host :
domestic rabbit
conjugate :
DyLight 550
clone name :
001
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP2-90327R
SKU :
NBP2-90327R
product name :
FGF-8 Antibody (001) [DyLight 550]
sizes available :
0.1 ml
description :
The FGF-8 Antibody (001) [DyLight 550] from NBP2-90327R is a 6.7e-05 antibody to . This antibody reacts with human.
target :
FGF-8
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Monoclonal
clone :
001
conjugate :
DyLight 550
all_available conjugate :
mFluor Violet 610 SE;DyLight 594;PE;Janelia Fluor 525;CoraFluor 1;Alexa Fluor 700;Alexa Fluor 594;Alexa Fluor 647;DyLight 550
dilution :
ELISA
host :
Rabbit
immunogen :
This antibody was obtained from a rabbit immunized with purified, recombinant Human FGF-8 (Accession#: NP_149355.1; Gln23-Arg204).
isotype :
IgG
purity :
Protein A purified
species :
Human
gene symbol :
FGF8
applications :
ELISA
extended description :
Recombinant Monoclonal Antibody
USD :
569 USD
product details :
Recombinant Monoclonal Antibody
alt names :
AIGFKAL6, Androgen-induced growth factor, FGF-8, fibroblast growth factor 8, fibroblast growth factor 8 (androgen-induced), HBGF-8, Heparin-binding growth factor 8, MGC149376
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments
